Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Uterine Neoplasms

fluorodeoxyglucose f18 has been researched along with Uterine Neoplasms in 107 studies

Research

Studies (107)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's39 (36.45)29.6817
2010's60 (56.07)24.3611
2020's8 (7.48)2.80

Authors

AuthorsStudies
Murakami, T; Nogami, M; Ueno, YR; Yokoo, S; Zeng, F1
Gerke, O; Hildebrandt, MG; Holm, J; Jensen, PT; Jochumsen, KM; Spasojevic, D; Sponholtz, SE; Thomassen, A; Vilstrup, MH1
Araz, M; Bakırarar, B; Ortaç, UF; Soydal, Ç; Taşkın, S; Varlı, B1
Iwamoto, S; Takeda, K; Yasumatsu, R1
Liu, W; Ou, X; Yao, X1
Cheng, W; Huo, L; Liu, M; Wang, P1
Bi, H; Dong, A; Ji, X1
Lancellotti, P; Matsuyama, E; Mitamura, H; Nagatomo, Y; Tsugu, T1
Cheon, GJ; Chung, HH; Kang, SY; Lee, HJ; Lee, JJ; Lee, JW; Moon, SH; Park, JY1
Chen, H; Fu, H; Guo, X; Wu, H1
Sharma, P1
Fujino, K; Kaneda, H; Kimura, M; Kusunoki, S; Ota, T; Takeda, S; Terao, Y; Ujihira, T1
Kim, CK; Zukotynski, KA1
Kimura, H; Kiyono, Y; Okazawa, H; Shono, K; Tsujikawa, T; Tsuyoshi, H; Yamada, S; Yamamoto, M; Yoshida, Y1
Ou, X; Shen, Y; Su, M; Yao, Y1
Atri, M; Bandos, AI; Gee, MS; Gold, MA; Lee, SI; Mannel, RS1
Bhosale, PR; Devine, C; Faria, S; Javadi, S; Korivi, BR; Viswanathan, C1
Grigsby, PW; Rao, YJ1
Alberini, JL; Bélissant, O; Champion, L; Thevenet, H; Weinmann, P1
Kato, K; Kondo, E; Umayahara, K; Usami, T; Yamamoto, A1
Cui, F; Su, M; Tian, R; Wang, H; Wu, X1
Chen, P; He, W; Li, J; Ouyang, R; Peng, H; Zong, D1
Abu Saadeh, F; Cormack, CM; Gleeson, N; Riain, CO1
Hirata, K; Iyama, Y; Kidoh, M; Nagayama, Y; Nakagawa, M; Nakaura, T; Namimoto, T; Oda, S; Sakamoto, F; Shiraishi, S; Yamashita, Y1
Dong, A; Wang, Y; Xiao, Z1
Buchpiguel, CA; Carvalho, FM; Carvalho, JP; Nunes, RF; Queiroz, MA1
Kiyono, Y; Kurokawa, T; Mori, T; Okazawa, H; Yoshida, Y; Zhao, Z1
Alraiyes, AH; Bernal-Green, L; Daroca, P; Hirsh, S; Kheir, F; Salerno, D1
Allende-Riera, A; Cárdenas-Negro, C; De Sequera-Rahola, M; Muñoz-Iglesias, J; Uña-Gorospe, J1
Giovanella, L; Hasanzadeh, M; Kadkhodayan, S; Sadeghi, R; Treglia, G; Zakavi, SR1
Chen, F; Mi, B; Wan, W; You, X; Yu, C1
Alberini, JL; Fréneaux, P; Jehanno, N; Malhaire, C; Petras, S; Wartski, M1
Chen, Y; Huang, Z; Rao, M; Zhang, L; Zhu, Y1
Chondrogiannis, S; Colletti, PM; Fuster, D; Giammarile, F; Grassetto, G; Maffione, AM; Marzola, MC; Musto, A; Rampin, L; Rubello, D1
An, YS; Lee, DH; Lee, SJ; Yoon, JK; Yoon, SH1
Catalano, OA; Dehdashti, F; Lee, SI1
Lu, D; Qin, L; Shen, J; Tian, X; Zhang, R1
Brunetti, JC1
Chen, Y; Huang, Z; Zhang, Y; Zhou, F1
Ijichil, S; Kitawaki, J; Nishigaki, H; Okuda, T; Yamashita, S; Yoshioka, T1
Kim, DY; Kim, JH; Kim, MH; Kim, YM; Kim, YT; Lee, HJ; Lee, JJ; Nam, JH; Park, JY; Suh, DS1
Cheon, GJ; Chung, HH; Heo, EJ; Kim, HS; Lee, H; Lee, JW; Lee, M; Moon, SH1
Dong, A; Gong, J; Jing, W; Wang, L; Wang, Y; Yang, P; Zhang, X1
Chang, CJ; Chang, WY; Chang, YC; Chao, A; Chou, HH; Hong, JH; Huang, SH; Huang, YE; Lai, CH; Lin, G; Liu, FY; Peng, NJ; Wang, CC; Yang, LY; Yen, TC1
Ma, Y; Shao, X; Wang, X; Wang, Y1
Dubreuil, J; Giammarile, F; Rubello, D; Skanjeti, A; Tordo, J1
Chino, Y; Kiyono, Y; Kurokawa, T; Mori, T; Okazawa, H; Shinagawa, A; Tsujikawa, T; Yamada, S; Yamamoto, M; Yoshida, Y1
Fujibayashi, Y; Kotsuji, F; Kurokawa, T; Mori, T; Okazawa, H; Tsujikawa, T; Yoshida, Y1
Chen, YJ; Lai, CR; Liu, RS; Shen, SH; Shieh, HJ; Sung, PL; Wang, PH; Wen, KC; Yen, MS; Yuan, CC1
Kaji, Y; Kitajima, K; Murakami, K; Sugimura, K; Yamasaki, E2
Lucignani, G1
Domeki, Y; Kaji, Y; Kitajima, K; Morita, S; Murakami, K; Suganuma, N; Sugimura, K; Yamasaki, E1
Inoue, T; Inubushi, M; Kajihara, M; Kido, A; Miyagawa, M; Nishizawa, S; Shinohara, K1
Hata, K; Hata, T; Inubashiri, E; Kanenishi, K; Nishiyama, Y; Ohkawa, M; Ohno, M; Shiota, A; Yamamoto, Y1
di Scioscio, V; Fabbri, M; Fasano, L; Feraco, P; Malvi, D; Miglio, L; Pacilli, AM; Toni, F; Zompatori, M1
Hiyama, A; Hori, K; Kawakami, Y; Matsunaga, N; Nawata, S; Suga, K1
Garg, G; Jaimini, A; Kaur, P; Mandal, A; Sharma, R; Singh, N; Souza, MD; Srivastava, M; Tripathi, M1
Ak, I; Ozalp, S1
Bauduceau, O; Bonardel, G; Chargari, C; Dechaud, C; Fayolle, M; Foehrenbach, H; Gontier, E; Soret, M1
Li, L; Nagamatsu, A; Tanaka, T; Umesaki, N1
Fan, W; Hu, Y; Lang, P; Lin, X; Sun, X; Zhang, X1
Kaji, Y; Kitajima, K; Murakami, K; Sugimura, K1
de Geus-Oei, LF; Flucke, UE; Oyen, WJ; van der Kogel, AJ; van der Meer, JW; Vierhout, ME; Vriens, D1
Ben-Ishay, O; Brauner, E; Kluger, Y; Shmulevsky, P; Vladowsy, E1
Brink, I; Denschlag, D; Gitsch, G; Hancke, K; Klar, M; Meyer, PT; Orlowska-Volk, M1
Han, JY; Hyun, IY; Lee, BI; Moon, YS; Park, JH1
Avril, N; Gourtsoyianni, S; Reznek, R1
Kaji, Y; Kitajima, K; Murakami, K; Sakamoto, S; Sugimura, K1
Ciarallo, A; Derbekyan, V; Hickeson, M; Makis, W1
Kao, YH; Magsombol, BM; Padhy, AK; Saad, U; Tan, AE1
Kiyono, Y; Kotsuji, F; Kurokawa, T; Okazawa, H; Tsujikawa, T; Yoshida, Y1
Hong, IK; Kim, DY1
Bai, RJ; Gao, S; Li, YJ; Sun, HR; Zhan, FH; Zhang, HJ1
Bal, C; Jain, SK; Jeph, S; Kumar, R; Malhotra, A; Sharma, DN; Sharma, JB; Sharma, P; Singh, H1
Chiewvit, S1
Imai, Y; Kita, M; Senda, M; Takaoka, A; Yamane, T1
Chung, HH; Chung, JK; Kang, KW; Kang, SB; Kim, JW; Park, NH; Song, YS1
Bar-On, S; Even-Sapir, E; Grisaru, D; Helpman, L; Lerman, H1
Abe, K; Baba, S; Honda, H; Isoda, T; Kubo, Y; Maruoka, Y; Matsuo, Y; Ogawa, S; Sasaki, M; Yano, T1
Akazawa, K; Hibino, M; Hikino, K; Oe, M1
Kao, CH1
Kawabe, J; Koyama, K; Miyama, M; Ochi, H; Okamura, T; Ozawa, N; Torii, K; Umesaki, N; Yamada, R1
Cher, S; Lay Ergun, E1
Bourguet, P1
Futatsubashi, M; Kanno, T; Maeda, M; Nakamura, F; Okada, H; Ouchi, Y; Takekuma, M; Torizuka, T; Yoshikawa, E1
Dehdashti, F; Grigsby, PW; Herzog, TJ; Siegel, BA; Tran, BN1
Ak, I; Ozalp, S; Vardareli, E; Yalçin, OT; Zor, E1
Dehdashti, F; Gibb, RK; Grigsby, PW; Herzog, TJ; Horowitz, NS; Mutch, DG; Powell, MA; Rader, JS; Siegel, BA1
Barranger, E; Daraï, E; Grahek, D; Talbot, JN; Uzan, S1
Cho, DS; Hong, EK; Kang, KW; Kim, JY; Kim, SK; Lee, JS; Lee, S; Park, SY; Roh, JW; Seo, SS; Sim, JS1
Arai, Y; Daisaki, H; Hasegawa, T; Maeda, T; Sasajima, Y; Sugimura, K; Tateishi, U1
Fukuda, H; Hakamatsuka, T; Higano, S; Kaneta, T; Sato, A; Takahashi, S; Yamada, S; Yamada, T1
Grahek, D; Talbot, JN1
Kanno, T; Maeda, M; Nakamura, F; Ogusu, T; Okada, H; Ouchi, Y; Takekuma, M; Torizuka, T; Yoshikawa, E1
Bonichon, F; Bosquet, L; Bourguet, P; Corone, C; Giard-Lefèvre, S; Hitzel, A; Houvenaeghel, G; Morett, JL; Touboul, E; Vinatier, D1
Cherng, SC; Chiu, CS; Fan, YM; Liou, CH; Yuan, YN1
Bosquet, L; Bourguet, P; Hitzel, A; Houvenaeghel, G; Vinatier, D1
Bettinardi, V; Fazio, F; Galimberti, S; Landoni, C; Mangioni, C; Messa, C; Perego, P; Picchio, M; Signorelli, M; Sironi, S1
Chura, JC; Downs, LS; Geller, MA; Johnson, L; Judson, PL; Truskinovsky, AM1
Chang, WC; Hung, YC; Kao, CH; Shen, HP1
Blondet, C; Cimarelli, S; Constantinesco, A; Fohrer, C; Herbrecht, R; Imperiale, A1
Berdel, WE; Bremer, C; Brunnberg, U; Mesters, RM; Müller-Tidow, C; Schleicher, C; Schliemann, C; Schmidt, E; Staebler, A; Stegger, L; Thoennissen, NH1
Lee, WL; Wang, PH; Yuan, CC1
Chang, TC; Ho, KC; Hsueh, S; Huang, HJ; Lai, CH; Lin, G; Ng, KK; Wang, CC; Wu, TI; Yen, TC1
Kawabe, J; Kawamura, N; Koyama, K; Miyama, M; Ochi, H; Ogita, S; Okamura, T; Tanaka, T; Umesaki, N1

Reviews

17 review(s) available for fluorodeoxyglucose f18 and Uterine Neoplasms

ArticleYear
Molecular Imaging and Precision Medicine in Uterine and Ovarian Cancers.
    PET clinics, 2017, Volume: 12, Issue:4

    Topics: Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging, Interventional; Molecular Imaging; Neoplasm Staging; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Precision Medicine; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Neoplasms

2017
FDG-PET Assessment of Other Gynecologic Cancers.
    PET clinics, 2018, Volume: 13, Issue:2

    Topics: Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiographic Image Enhancement; Sensitivity and Specificity; Uterine Neoplasms; Vaginal Neoplasms; Vulvar Neoplasms

2018
The Role of PET Imaging in Gynecologic Radiation Oncology.
    PET clinics, 2018, Volume: 13, Issue:2

    Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Middle Aged; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiation Oncology; Radiographic Image Enhancement; Sensitivity and Specificity; Uterine Cervical Neoplasms; Uterine Neoplasms; Vulvar Neoplasms

2018
Concurrent benign metastasizing leiomyoma in the lung and lumbar spine with elevated standardized uptake value level in positron-emission tomography computed tomography: A case report and literature review.
    Medicine, 2018, Volume: 97, Issue:27

    Topics: Diagnosis, Differential; Estrogen Antagonists; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Lumbar Vertebrae; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Spinal Neoplasms; Tamoxifen; Uterine Neoplasms

2018
Lung metastases from benign uterine leiomyoma: does 18-FDG-PET/CT have a role to play?
    Irish journal of medical science, 2019, Volume: 188, Issue:2

    Topics: Female; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Lung Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Uterine Neoplasms

2019
Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography imaging in uterine sarcomas: systematic review and meta-analysis of the literature.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2013, Volume: 23, Issue:8

    Topics: Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Uterine Neoplasms

2013
Role of 18F-FDG PET/CT in the carcinoma of the uterus: a review of literature.
    Yonsei medical journal, 2014, Volume: 55, Issue:6

    Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Neoplasms; Uterus

2014
Evaluation of gynecologic cancer with MR imaging, 18F-FDG PET/CT, and PET/MR imaging.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:3

    Topics: Coordination Complexes; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Recurrence, Local; Organometallic Compounds; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Salvage Therapy; Thiosemicarbazones; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Uterine Neoplasms

2015
Fludeoxyglucose F 18 PET-Computed Tomography: Management Changes Effecting Patient Outcomes in Gynecologic Malignancies.
    PET clinics, 2015, Volume: 10, Issue:3

    Topics: Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Neoplasms

2015
Diffusion-weighted MRI and 18F-FDG-PET/CT imaging: competition or synergy as diagnostic methods to manage sarcoma of the uterus? A systematic review of the literature.
    Nuclear medicine communications, 2017, Volume: 38, Issue:1

    Topics: Diffusion Magnetic Resonance Imaging; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoma; Uterine Neoplasms

2017
FDG-PET in gynaecological cancers: recent observations.
    European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:11

    Topics: Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Ovarian Neoplasms; Positron-Emission Tomography; Radiography; Uterine Neoplasms

2008
[Positron emission tomography in the management of cervix cancer patients].
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2009, Volume: 13, Issue:6-7

    Topics: Adenocarcinoma; Adult; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Uterine Cervical Neoplasms; Uterine Neoplasms

2009
Spectrum of FDG PET/CT findings of uterine tumors.
    AJR. American journal of roentgenology, 2010, Volume: 195, Issue:3

    Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Magnetic Resonance Imaging; Positron-Emission Tomography; Precancerous Conditions; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed; Uterine Neoplasms

2010
Benign uterine uptake of FDG: a case report and review of literature.
    The Netherlands journal of medicine, 2010, Volume: 68, Issue:9

    Topics: Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Leiomyoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Ultrasonography; Uterine Neoplasms; Uterus

2010
Established, emerging and future applications of FDG-PET/CT in the uterine cancer.
    Clinical radiology, 2011, Volume: 66, Issue:4

    Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Uterine Neoplasms

2011
[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in gynecological neoplasms].
    Bulletin du cancer, 2003, Volume: 90 Spec No

    Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Neoplasms; Vaginal Neoplasms

2003
[Role of [18F]-fluorodeoxyglucose positron emission tomography for the initial detection, staging, search for recurrences and restaging of gynaecological and breast cancers].
    Gynecologie, obstetrique & fertilite, 2005, Volume: 33, Issue:6

    Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Uterine Cervical Neoplasms; Uterine Neoplasms

2005

Trials

9 trial(s) available for fluorodeoxyglucose f18 and Uterine Neoplasms

ArticleYear
18F-FES and 18F-FDG PET for differential diagnosis and quantitative evaluation of mesenchymal uterine tumors: correlation with immunohistochemical analysis.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Estradiol; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Humans; Immunohistochemistry; Ki-67 Antigen; Leiomyoma; Middle Aged; Positron-Emission Tomography; Sarcoma; Uterine Neoplasms

2013
Utility of (18)F-FDG PET/CT in patients with advanced squamous cell carcinoma of the uterine cervix receiving concurrent chemoradiotherapy: a parallel study of a prospective randomized trial.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Uterine Neoplasms

2016
Additional value of 16α-[18F]fluoro-17β-oestradiol PET for differential diagnosis between uterine sarcoma and leiomyoma in patients with positive or equivocal findings on [18F]fluorodeoxyglucose PET.
    European journal of nuclear medicine and molecular imaging, 2011, Volume: 38, Issue:10

    Topics: Adult; Aged; Biological Transport; Diagnosis, Differential; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Middle Aged; Positron-Emission Tomography; Prospective Studies; Sarcoma; Uterine Neoplasms

2011
18F-FLT PET performs better than 18F-FDG PET in differentiating malignant uterine corpus tumors from benign leiomyoma.
    Annals of nuclear medicine, 2012, Volume: 26, Issue:6

    Topics: Adult; Aged; Biological Transport; Cell Proliferation; Diagnosis, Differential; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Middle Aged; Positron-Emission Tomography; Uterine Neoplasms

2012
Predictive role of post-treatment [18F]FDG PET/CT in patients with uterine cervical cancer.
    European journal of radiology, 2012, Volume: 81, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Uterine Neoplasms; Young Adult

2012
Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:7

    Topics: Adenocarcinoma; Adult; Aged; Carbon Radioisotopes; Carcinoma, Squamous Cell; Carcinosarcoma; Choline; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sarcoma; Sarcoma, Clear Cell; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Neoplasms; Whole-Body Counting

2003
Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer.
    Gynecologic oncology, 2004, Volume: 95, Issue:3

    Topics: Aorta; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Pelvis; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Uterine Neoplasms

2004
FDG PET for the assessment of myometrial infiltration in clinical stage I uterine corpus cancer.
    Nuclear medicine communications, 2006, Volume: 27, Issue:6

    Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Myometrium; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Uterine Neoplasms

2006
Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET/CT in the detection of recurrence.
    European journal of nuclear medicine and molecular imaging, 2007, Volume: 34, Issue:4

    Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Population Surveillance; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Systems Integration; Tomography, X-Ray Computed; Treatment Outcome; Uterine Neoplasms

2007

Other Studies

81 other study(ies) available for fluorodeoxyglucose f18 and Uterine Neoplasms

ArticleYear
FDG PET/MRI in Synchronous Uterine Adenocarcinoma and Leiomyosarcoma.
    Clinical nuclear medicine, 2022, Jun-01, Volume: 47, Issue:6

    Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Magnetic Resonance Imaging; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Neoplasms

2022
Improved stratification of stage-specific survival for cervical uterine cancer by integrating FDG-PET/CT and MRI for lymph node staging in 2018 FIGO classification.
    Gynecologic oncology, 2022, Volume: 167, Issue:2

    Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Uterine Cervical Neoplasms; Uterine Neoplasms

2022
Radiomics analysis of uterine tumors in 18F-fluorodeoxyglucose positron emission tomography for prediction of lymph node metastases in endometrial carcinoma.
    Turkish journal of medical sciences, 2022, Volume: 52, Issue:3

    Topics: Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Uterine Neoplasms

2022
Aberrant Hypermetabolism of Nasal Leiomyoma Mimicking Malignancy on 18 F-FDG PET/CT.
    Clinical nuclear medicine, 2023, Mar-01, Volume: 48, Issue:3

    Topics: Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Leiomyosarcoma; Nose Neoplasms; Positron Emission Tomography Computed Tomography; Uterine Neoplasms

2023
Hypermetabolic Subserosal Uterine Leiomyoma With Synchronous Atypical Multiple Myeloma Mimicking Ovarian Malignancy With Multiple Bone Metastases on 18F-FDG PET/CT.
    Clinical nuclear medicine, 2023, Feb-01, Volume: 48, Issue:2

    Topics: Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Middle Aged; Multiple Myeloma; Myoma; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Uterine Neoplasms

2023
Hypermetabolic Broad Ligament Leiomyoma in Postmenopausal Women Mimicking Ovarian Tumors on 18 F-FDG PET/CT.
    Clinical nuclear medicine, 2023, Apr-01, Volume: 48, Issue:4

    Topics: Broad Ligament; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Middle Aged; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Postmenopause; Uterine Neoplasms

2023
Multiple Cutaneous Leiomyomas Showing Increased FDG Uptake.
    Clinical nuclear medicine, 2020, Volume: 45, Issue:10

    Topics: Biological Transport; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Leiomyomatosis; Male; Neoplastic Syndromes, Hereditary; Skin Neoplasms; Uterine Neoplasms

2020
Very delayed sinus arrest during complete remission of diffuse large B-cell lymphoma invading right atrium.
    Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, 2021, Volume: 49, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bradycardia; Cyclophosphamide; Doxorubicin; Electrocardiography; Female; Fluorodeoxyglucose F18; Heart Atria; Heart Neoplasms; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Neoplasm Invasiveness; Positron Emission Tomography Computed Tomography; Prednisone; Remission Induction; Rituximab; Sinus Arrest, Cardiac; Uterine Neoplasms; Vincristine

2021
Prognostic significance of preoperative ¹⁸F-FDG PET/CT in uterine leiomyosarcoma.
    Journal of gynecologic oncology, 2017, Volume: 28, Issue:3

    Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Period; Radiopharmaceuticals; Retrospective Studies; Uterine Neoplasms

2017
Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome Combined With Adrenocortical Carcinoma on 18F-FDG PET/CT.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:9

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Leiomyomatosis; Neoplastic Syndromes, Hereditary; Positron Emission Tomography Computed Tomography; Skin Neoplasms; Uterine Neoplasms; Young Adult

2017
18F-FDG PET/CT Demonstrating Chorioadenoma Destruens After Evacuation of Complete Hydatidiform Mole.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:10

    Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Hydatidiform Mole, Invasive; Positron Emission Tomography Computed Tomography; Pregnancy; Uterine Neoplasms

2017
Efficacy of PET/CT to exclude leiomyoma in patients with lesions suspicious for uterine sarcoma on MRI.
    Taiwanese journal of obstetrics & gynecology, 2017, Volume: 56, Issue:4

    Topics: Adult; Aged; Area Under Curve; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Magnetic Resonance Imaging; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reference Values; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Uterine Neoplasms

2017
Assessment of intratumor heterogeneity in mesenchymal uterine tumor by an
    Annals of nuclear medicine, 2017, Volume: 31, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Mesoderm; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve; Uterine Neoplasms

2017
Uterine Metastasis From Gastric Adenocarcinoma Masquerading as Physiologic Endometrial Uptake in FDG PET/CT.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:12

    Topics: Adenocarcinoma; Adult; Biological Transport; Endometrium; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Stomach Neoplasms; Uterine Neoplasms

2017
Identification of Distant Metastatic Disease in Uterine Cervical and Endometrial Cancers with FDG PET/CT: Analysis from the ACRIN 6671/GOG 0233 Multicenter Trial.
    Radiology, 2018, Volume: 287, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Societies, Medical; United States; Uterine Neoplasms

2018
Value of 18F-FDG PET/CT imaging in the staging, restaging, monitoring of response to therapy and surveillance of uterine leiomyosarcomas.
    Nuclear medicine communications, 2018, Volume: 39, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Survival Analysis; Treatment Outcome; Uterine Neoplasms

2018
A case report of benign metastasizing leiomyoma of the lung: FDG-PET-CT findings and the utility of uterine needle biopsy.
    European journal of gynaecological oncology, 2016, Volume: 37, Issue:4

    Topics: Biopsy; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Lung Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Uterine Neoplasms

2016
Uterine Corpus Metastasis From Rectal Adenocarcinoma Detected Using 18F-FDG PET/CT.
    Clinical nuclear medicine, 2018, Volume: 43, Issue:8

    Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Rectal Neoplasms; Uterine Neoplasms

2018
A multiparametric MRI-based machine learning to distinguish between uterine sarcoma and benign leiomyoma: comparison with
    Clinical radiology, 2019, Volume: 74, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Leiomyoma; Machine Learning; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Uterine Neoplasms; Uterus; Young Adult

2019
Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome-Associated Renal Cell Carcinoma Showing High FDG Uptake.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:5

    Topics: Adult; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Leiomyomatosis; Neoplastic Syndromes, Hereditary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms; Uterine Neoplasms

2019
Aberrant Hypermetabolism of Benign Uterine Leiomyoma on 18F-FDG PET/CT.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:6

    Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Uterine Neoplasms; Uterus

2019
A 40-year-old woman with multiple lung nodules.
    Chest, 2013, Volume: 143, Issue:6

    Topics: Adult; Biopsy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Hypertension; Kidney Failure, Chronic; Leiomyoma; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiography, Thoracic; Radiopharmaceuticals; Thoracic Surgery, Video-Assisted; Thoracoscopy; Tomography, X-Ray Computed; Uterine Neoplasms

2013
Unsuspected uterine metastasis of breast carcinoma diagnosed by 18F-FDG PET/CT.
    Clinical nuclear medicine, 2013, Volume: 38, Issue:11

    Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Uterine Neoplasms

2013
Carcinosarcoma of the uterine corpus on 18F-FDG PET/CT in a postmenopausal woman with elevated AFP.
    Clinical nuclear medicine, 2014, Volume: 39, Issue:9

    Topics: Aged; alpha-Fetoproteins; Carcinosarcoma; Female; Fluorodeoxyglucose F18; Humans; Mixed Tumor, Mullerian; Multimodal Imaging; Positron-Emission Tomography; Postmenopause; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Neoplasms

2014
18F-FDG PET/CT findings in uterine leiomyomas.
    European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:5

    Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Neoplasms

2014
Primary pancreatic choriocarcinoma revealed on FDG PET/CT.
    Clinical nuclear medicine, 2015, Volume: 40, Issue:1

    Topics: Adult; Choriocarcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Pregnancy; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Neoplasms

2015
Physiologic facial muscle uptake on 18F-FDG PET/CT by chewing-like habitual movement in patient with Sjögren syndrome.
    Clinical nuclear medicine, 2015, Volume: 40, Issue:3

    Topics: Aged, 80 and over; Diagnosis, Differential; Facial Muscles; Female; Fluorodeoxyglucose F18; Humans; Mastication; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sjogren's Syndrome; Tomography, X-Ray Computed; Uterine Neoplasms

2015
High 18F-FDG uptake for uterine smooth muscle tumor of uncertain malignant potential.
    Clinical nuclear medicine, 2015, Volume: 40, Issue:4

    Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Smooth Muscle Tumor; Tomography, X-Ray Computed; Uterine Neoplasms

2015
Adenocarcinoma of the Cervix Uteri and Endometrium Combined With the Kartagener Syndrome on FDG PET/CT.
    Clinical nuclear medicine, 2015, Volume: 40, Issue:11

    Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Kartagener Syndrome; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Neoplasms

2015
Diagnostic usefulness of FDG-PET/CT in advanced malignant lymphoma of the uterus: report of two cases.
    European journal of gynaecological oncology, 2015, Volume: 36, Issue:6

    Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Neoplasms

2015
Comparison of MRI and 18F-FDG PET/CT in the preoperative evaluation of uterine carcinosarcoma.
    Gynecologic oncology, 2016, Volume: 140, Issue:3

    Topics: Aged; Aorta; Carcinosarcoma; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pelvis; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Period; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Uterine Neoplasms

2016
Prognostic value of total lesion glycolysis on preoperative
    European radiology, 2016, Volume: 26, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Carcinosarcoma; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Kaplan-Meier Estimate; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden; Uterine Neoplasms

2016
Primary Uterine Peripheral T-cell Lymphoma: A Case Report of MRI and 18F-FDG PET/CT Findings.
    Medicine, 2016, Volume: 95, Issue:17

    Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Lymphoma, T-Cell, Peripheral; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity; Uterine Neoplasms; Uterus

2016
High metabolic characteristics of uterine fibroids in 18F-FDG PET/CT imaging and the underlying mechanisms.
    Nuclear medicine communications, 2016, Volume: 37, Issue:11

    Topics: Adult; Aged; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hormones; Humans; Leiomyoma; Logistic Models; Menopause; Menstrual Cycle; Middle Aged; Multivariate Analysis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Uterine Neoplasms

2016
18F-FDG/18F-FES standardized uptake value ratio determined using PET predicts prognosis in uterine sarcoma.
    Oncotarget, 2017, Apr-04, Volume: 8, Issue:14

    Topics: Estradiol; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sarcoma; Survival Rate; Uterine Neoplasms

2017
Uterine tumors: pathophysiologic imaging with 16alpha-[18F]fluoro-17beta-estradiol and 18F fluorodeoxyglucose PET--initial experience.
    Radiology, 2008, Volume: 248, Issue:2

    Topics: Analysis of Variance; Estradiol; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Neoplasms

2008
Whole-body positron emission tomography with 18F-fluorodeoxyglucose is an effective method to detect extra-pelvic recurrence in uterine sarcomas.
    European journal of gynaecological oncology, 2008, Volume: 29, Issue:3

    Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Sarcoma; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Neoplasms; Whole Body Imaging

2008
Standardized uptake values of uterine leiomyoma with 18F-FDG PET/CT: variation with age, size, degeneration, and contrast enhancement on MRI.
    Annals of nuclear medicine, 2008, Volume: 22, Issue:6

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Body Size; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Neoplasms

2008
Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent uterine cancer: comparison with PET and enhanced CT.
    European journal of nuclear medicine and molecular imaging, 2009, Volume: 36, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Neoplasms

2009
Incidence and characteristics of uterine leiomyomas with FDG uptake.
    Annals of nuclear medicine, 2008, Volume: 22, Issue:9

    Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Incidence; Japan; Leiomyoma; Middle Aged; Postmenopause; Premenopause; Radionuclide Imaging; Radiopharmaceuticals; Risk Assessment; Risk Factors; Uterine Neoplasms

2008
Accuracy of integrated FDG-PET/contrast-enhanced CT in detecting pelvic and paraaortic lymph node metastasis in patients with uterine cancer.
    European radiology, 2009, Volume: 19, Issue:6

    Topics: Adult; Aged; Aorta; Aortography; Carcinoma; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Systems Integration; Tomography, X-Ray Computed; Uterine Neoplasms

2009
Positron emission tomography with the glucose analog [F]-fluoro-2-deoxy-D-glucose for evaluating pelvic lymph node metastasis in uterine corpus cancer: comparison with CT and MRI findings.
    The journal of obstetrics and gynaecology research, 2009, Volume: 35, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Neoplasms

2009
Benign metastasizing leiomyoma of the lung: PET findings.
    Journal of thoracic imaging, 2009, Volume: 24, Issue:1

    Topics: Biopsy, Needle; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Lung Neoplasms; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Neoplasms

2009
F-18 FDG PET/CT findings of a case of complete hydatidiform mole.
    Clinical nuclear medicine, 2009, Volume: 34, Issue:5

    Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Hydatidiform Mole; Positron-Emission Tomography; Pregnancy; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Neoplasms

2009
Suppression of F-18 fluorodeoxyglucose uptake in benign uterine leiomyomas with danazol.
    Clinical nuclear medicine, 2009, Volume: 34, Issue:7

    Topics: Adult; Danazol; Estrogen Antagonists; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Myometrium; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Neoplasms

2009
Prognostic relevance of F-18 fluorodeoxyglucose positron emission tomography and computed tomography in molar pregnancy before evacuation.
    The Journal of reproductive medicine, 2009, Volume: 54, Issue:7

    Topics: Adolescent; Adult; Antineoplastic Agents; Chorionic Gonadotropin, beta Subunit, Human; Female; Fluorodeoxyglucose F18; Humans; Hydatidiform Mole; Middle Aged; Positron-Emission Tomography; Pregnancy; Prognosis; Uterine Neoplasms; Uterus; Young Adult

2009
Use of 18F-fluorodeoxyglucose positron emission tomography for diagnosis of uterine sarcomas.
    Oncology reports, 2010, Volume: 23, Issue:4

    Topics: Excitatory Amino Acid Transporter 2; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Immunohistochemistry; L-Lactate Dehydrogenase; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Uterine Neoplasms

2010
Benign metastasizing leiomyoma identified using 18F-FDG PET/CT.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2010, Volume: 110, Issue:2

    Topics: Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Lung Neoplasms; Middle Aged; Pelvic Neoplasms; Positron-Emission Tomography; Uterine Neoplasms

2010
Mucosal small bowel metastasis from uterine leiomyosarcoma.
    The Israel Medical Association journal : IMAJ, 2010, Volume: 12, Issue:5

    Topics: Contrast Media; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Intestinal Mucosa; Intestinal Neoplasms; Intestine, Small; Leiomyosarcoma; Middle Aged; Obesity, Morbid; Positron-Emission Tomography; Radiographic Image Enhancement; Uterine Neoplasms

2010
Evaluation of FDG-PET for detecting lymph node metastasis in uterine corpus cancer.
    Anticancer research, 2010, Volume: 30, Issue:9

    Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Uterine Neoplasms

2010
Case of uterine leiomyoma showing fludeoxyglucose uptake on F-18 fludeoxyglucose positron emission tomography/computed tomography.
    The journal of obstetrics and gynaecology research, 2010, Volume: 36, Issue:6

    Topics: False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Middle Aged; Positron-Emission Tomography; Postmenopause; Radiopharmaceuticals; Uterine Neoplasms

2010
Gynecological cancers.
    Methods in molecular biology (Clifton, N.J.), 2011, Volume: 727

    Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Neoplasms

2011
Malignant perivascular epithelioid cell tumor (PEComa) of the uterus: serial imaging with F-18 FDG PET/CT for surveillance of recurrence and evaluation of response to therapy.
    Clinical nuclear medicine, 2011, Volume: 36, Issue:4

    Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Perivascular Epithelioid Cell Neoplasms; Positron-Emission Tomography; Recurrence; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Uterine Neoplasms

2011
Fluorine-18-fluorodeoxyglucose PET/CT for the evaluation of suspected recurrent uterine leiomyosarcomas.
    Acta radiologica (Stockholm, Sweden : 1987), 2011, May-01, Volume: 52, Issue:4

    Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Uterine Neoplasms

2011
F-18 FDG PET/CT of a uterine smooth-muscle tumor of unknown malignant potential.
    Clinical nuclear medicine, 2011, Volume: 36, Issue:10

    Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Muscle, Smooth; Positron-Emission Tomography; Tomography, X-Ray Computed; Uterine Neoplasms

2011
Fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging of uterine leiomyosarcomas: 2 cases report.
    Chinese medical journal, 2011, Volume: 124, Issue:14

    Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Uterine Neoplasms

2011
Role of FDG PET-CT in detecting recurrence in patients with uterine sarcoma: comparison with conventional imaging.
    Nuclear medicine communications, 2012, Volume: 33, Issue:2

    Topics: Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Neoplasms

2012
18F-FDG avid in uterine leiomyoma: a case report.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2012, Volume: 95, Issue:2

    Topics: Adult; Comorbidity; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Leiomyoma; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Neoplasms

2012
Estrogen-dependent variations in 18F-fluorodeoxyglucose uptake in uterine leiomyomas.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2012, Volume: 22, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Estrogens; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hormone Replacement Therapy; Humans; Israel; Leiomyoma; Menopause; Menstrual Cycle; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tertiary Care Centers; Uterine Neoplasms; Young Adult

2012
A case of pulmonary choriocarcinoma metastasis with unusual FDG-PET and CT findings: correlation with pathology.
    Annals of nuclear medicine, 2012, Volume: 26, Issue:10

    Topics: Adult; Choriocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Pregnancy; Tomography, X-Ray Computed; Uterine Neoplasms

2012
Pulmonary tumor embolism secondary to uterine corpus carcinosarcoma mimicking pulmonary thromboembolism.
    Internal medicine (Tokyo, Japan), 2012, Volume: 51, Issue:18

    Topics: Carcinosarcoma; Diagnosis, Differential; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Neoplastic Cells, Circulating; Positron-Emission Tomography; Pulmonary Artery; Pulmonary Embolism; Tomography, X-Ray Computed; Uterine Neoplasms

2012
FDG uptake in a huge uterine myoma.
    Clinical nuclear medicine, 2003, Volume: 28, Issue:3

    Topics: Abdomen; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Middle Aged; Palpation; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Neoplasms

2003
Evaluation of 18F-FDG PET with bladder irrigation in patients with uterine and ovarian tumors.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Artifacts; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Radiopharmaceuticals; Therapeutic Irrigation; Tomography, Emission-Computed; Urinary Bladder; Uterine Cervical Neoplasms; Uterine Neoplasms

2003
Positron emission tomographic-computed tomographic imaging of a uterine sarcoma.
    Clinical nuclear medicine, 2003, Volume: 28, Issue:5

    Topics: Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Leiomyosarcoma; Middle Aged; Radiopharmaceuticals; Subtraction Technique; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Neoplasms

2003
Occult supraclavicular lymph node metastasis identified by FDG-PET in patients with carcinoma of the uterine cervix.
    Gynecologic oncology, 2003, Volume: 90, Issue:3

    Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Neoplasms

2003
[2003 update of recommendations for clinical practice: standards, options and recommendations for the use of FDG-PET in the management of gynaecological and breast cancers].
    Gynecologie, obstetrique & fertilite, 2004, Volume: 32, Issue:4

    Topics: Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Neoplasm Metastasis; Neoplasm, Residual; Ovarian Neoplasms; Tomography, Emission-Computed; Uterine Neoplasms; Vaginal Neoplasms

2004
Uptake of 2-[18F]fluoro-2-deoxy-D-glucose in uterine leiomyoma: imaging of four patients by coincidence positron emission tomography.
    Nuclear medicine communications, 2004, Volume: 25, Issue:9

    Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Uterine Neoplasms

2004
Role of positron emission tomography in pretreatment lymph node staging of uterine cervical cancer: a prospective surgicopathologic correlation study.
    European journal of cancer (Oxford, England : 1990), 2005, Volume: 41, Issue:14

    Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Uterine Neoplasms

2005
Atypical polypoid adenomyoma of the uterus: appearance on (18)F-FDG PET/MRI fused images.
    AJR. American journal of roentgenology, 2006, Volume: 186, Issue:2

    Topics: Adenomyoma; Adult; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Neoplasms

2006
Prolapsed endometrial cancer: FDG PET/CT findings.
    Clinical nuclear medicine, 2006, Volume: 31, Issue:3

    Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Prognosis; Prolapse; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Uterine Neoplasms

2006
[Update of 'standards, options and recommendations' for FDG-PET in breast and gynaecological cancers].
    Gynecologie, obstetrique & fertilite, 2006, Volume: 34, Issue:5

    Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; France; Genital Neoplasms, Female; Humans; Neoplasm Metastasis; Ovarian Neoplasms; Practice Guidelines as Topic; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Neoplasms; Vaginal Neoplasms

2006
[Synthesis bulletin of 2005 surveillance. Clinical practice recommendations: the use of PET-FDG in cancers of the breast, ovary and uterus].
    Bulletin du cancer, 2006, Volume: 93, Issue:4

    Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Neoplasms

2006
Intense FDG uptake of metastatic clear cell carcinoma from the ovary in a uterine leiomyoma.
    Clinical nuclear medicine, 2006, Volume: 31, Issue:7

    Topics: Adenocarcinoma, Clear Cell; Antigens, Neoplasm; Biomarkers, Tumor; CA-125 Antigen; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Middle Aged; Neoplasms, Multiple Primary; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Neoplasms

2006
[2005 monitoring report: use of positron emission tomography with fluorodeoxyglucose in the management of patients with breast cancer, ovarian cancer, and uterine cancer].
    Gynecologie, obstetrique & fertilite, 2006, Volume: 34, Issue:5

    Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; France; Humans; Meta-Analysis as Topic; Neoplasm Metastasis; Ovarian Neoplasms; Practice Guidelines as Topic; Quality of Health Care; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Neoplasms

2006
Positron emission tomography and leiomyomas: clinicopathologic analysis of 3 cases of PET scan-positive leiomyomas and literature review.
    Gynecologic oncology, 2007, Volume: 104, Issue:1

    Topics: Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Neoplasms

2007
Choriocarcinoma with pulmonary metastasis: report of a case of successful treatment with serial FDG-PET follow-up.
    The Journal of reproductive medicine, 2007, Volume: 52, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Combined Modality Therapy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Lung Neoplasms; Positron-Emission Tomography; Pregnancy; Radiopharmaceuticals; Uterine Neoplasms

2007
[18F]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography for early evaluation of treatment efficacy in advanced non-Hodgkin lymphoma of uterine corpus: a case report.
    Clinical lymphoma & myeloma, 2007, Volume: 7, Issue:6

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Methylprednisolone; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Rituximab; Treatment Outcome; Uterine Neoplasms; Vincristine

2007
Chemotherapy in metastatic malignant triton tumor: report on two cases.
    Oncology reports, 2007, Volume: 18, Issue:4

    Topics: Adult; Antineoplastic Agents; Cecal Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Ileal Neoplasms; Liver Neoplasms; Male; Neoadjuvant Therapy; Neurilemmoma; Neurofibromatosis 1; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Neoplasms

2007
Positron emission tomography and uterine leiomyomas.
    Gynecologic oncology, 2007, Volume: 107, Issue:3

    Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Leiomyosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Neoplasms

2007
18F-fluorodeoxyglucose positron emission tomography in uterine carcinosarcoma.
    European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Carcinosarcoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Neoplasms

2008
Positron emission tomography with (18)F-fluorodeoxyglucose of uterine sarcoma: a comparison with magnetic resonance imaging and power Doppler imaging.
    Gynecologic oncology, 2001, Volume: 80, Issue:3

    Topics: Aged; Carcinosarcoma; Female; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Magnetic Resonance Imaging; Middle Aged; Radiography; Radiopharmaceuticals; Sarcoma, Endometrial Stromal; Tomography, Emission-Computed; Ultrasonography, Doppler; Uterine Neoplasms

2001